Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

US Patent 10322168 · Granted Jun 18, 2019

Estimated economic value: $7,111,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stable epinephrine suspension formulation for inhalation with HFO propellant2025
Albuterol aerosol suspension formulation for oral inhalation with high amount of2025
Pro-insulin aspart structure and method for preparing insulin aspart2025
Small angle x-ray scattering methods for characterizing the iron core of iron ca2023
Highly purified recombinant human insulin (RHI) API and methods of producing the2022
Highly purified recombinant human insulin (RHI) API and methods of producing the2022
High-purity inhalable particles of insulin and insulin analogues, and high-effic2022
High-purity inhalable particles of insulin and insulin analogues, and high-effic2022
High-purity inhalable particles of insulin and insulin analogues, and high-effic2022
High-purity inhalable particles of insulin and insulin analogues, and high-effic2022
High-purity inhalable particles of insulin and insulin analogues, and high-effic2019
High-purity inhalable particles of insulin and insulin analogues, and high-effic2019